A detailed history of Bank Of Montreal transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 2,500 shares of IBRX stock, worth $12,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,500
Previous 2,500 -0.0%
Holding current value
$12,750
Previous $15,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.32 - $6.7 $832,988 - $1.68 Million
250,900 Added 2276.36%
261,922 $971,000
Q2 2024

Aug 14, 2024

SELL
$4.82 - $9.15 $69,408 - $131,760
-14,400 Reduced 56.64%
11,022 $69,000
Q1 2024

May 13, 2024

SELL
$3.23 - $6.17 $119,506 - $228,283
-36,999 Reduced 59.27%
25,422 $136,000
Q4 2023

Feb 08, 2024

BUY
$1.25 - $5.21 $17,576 - $73,257
14,061 Added 29.08%
62,421 $313,000
Q3 2023

Nov 01, 2023

BUY
$1.29 - $3.1 $62,384 - $149,916
48,360 New
48,360 $81,000
Q1 2023

Jun 13, 2024

BUY
$1.35 - $4.78 $102,663 - $363,504
76,047 Added 299.14%
101,469 $184,000
Q4 2022

Feb 01, 2023

BUY
$4.35 - $6.77 $874 - $1,360
201 Added 0.21%
97,961 $496,000
Q3 2022

Nov 10, 2022

BUY
$3.65 - $6.43 $356,824 - $628,596
97,760 New
97,760 $517,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $2.04B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.